In people without diabetes, higher plasma levels of BCAAs are associated with lower insulin sensitivity, reduced metabolic clearance of insulin, and higher fasting insulin concentrations (53), thereby linking high BCAA intake, potentially, to the development of insulin resistance, especially when paired with obesity (54). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.